|
Getting your Trinity Audio player ready...
|
— FDA Approvals, Deep Mineral Finds, AI-Powered Drug Leads, Global Health Vaccine and Wireless Signals, Solutions Capture Market Attention —
Tenon Medical (NASDAQ: TNON) earned FDA clearance for expanded use of its Catamaran® SI Joint Fusion System, now approved to support thoracolumbar spinal fusion—unlocking a larger surgical market opportunity.
Power Metallic Mines (TSXV: PNPN | OTCBB: PNPNF) announced its deepest assay yet from the Lion Zone and initial Ni/Cu results from the Tiger Zone. Borehole EM continues to pinpoint high-potential sulphide targets for expanded exploration.
Predictive Oncology (NASDAQ: POAI) leveraged AI and live-cell tumor data to model responses from 21 novel natural compounds. Several outperformed standard chemo drugs, pushing forward next-gen cancer drug discoveries.
Dyadic International (NASDAQ: DYAI) is accelerating global vaccine innovation with its C1 biomanufacturing platform, now funded by the Gates Foundation and CEPI. Designed to cut production time and costs, C1 enables rapid, affordable development of non-mRNA vaccines—including potential Bird Flu solutions. See Entire Article, read now!
Peraso Inc. (NASDAQ: PRSO) secured a $3.6 million order from a major client, boosting its mmWave wireless momentum. With Q2 2025 shipments underway and urban rollouts expanding in Los Angeles, CEO Ron Glibbery detailed the company’s breakthroughs on The Street Reports Podcast listen now.
These multi-sector breakthroughs showcase disruptive innovation in healthcare, biotech, mining, wireless signals and global health—driving market momentum and investor interest.